trending Market Intelligence /marketintelligence/en/news-insights/trending/VTrcc4yi4R-JaGOdzIAmeA2 content esgSubNav
In This List

AusCann appoints interim CEO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


AusCann appoints interim CEO

AusCann Group Holdings Ltd tapped Executive Director Paul MacLeman as interim CEO of the company, effective Jan. 1, 2019.

MacLeman will hold the position until the company finds a permanent replacement for Elaine Darby, who previously announced plans to step down as AusCann's managing director.

AusCann is an Australian pharmaceutical company focused on developing cannabinoid medicines.